title: Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity.
abstract: GPER/GPR30 is a seven-transmembrane G protein-coupled estrogen receptor that regulates many aspects of mammalian biology and physiology. We have previously described both a GPER-selective agonist G-1 and antagonist G15 based on a tetrahydro-3H-cyclopenta[c]quinoline scaffold. The antagonist lacks an ethanone moiety that likely forms important hydrogen bonds involved in receptor activation. Computational docking studies suggested that the lack of the ethanone substituent in G15 could minimize key steric conflicts, present in G-1, that limit binding within the ERα ligand binding pocket. In this report, we identify low-affinity cross-reactivity of the GPER antagonist G15 to the classical estrogen receptor ERα. To generate an antagonist with enhanced selectivity, we therefore synthesized an isosteric G-1 derivative, G36, containing an isopropyl moiety in place of the ethanone moiety. We demonstrate that G36 shows decreased binding and activation of ERα, while maintaining its antagonist profile towards GPER. G36 selectively inhibits estrogen-mediated activation of PI3K by GPER but not ERα. It also inhibits estrogen- and G-1-mediated calcium mobilization as well as ERK1/2 activation, with no effect on EGF-mediated ERK1/2 activation. Similar to G15, G36 inhibits estrogen- and G-1-stimulated proliferation of uterine epithelial cells in vivo. The identification of G36 as a GPER antagonist with improved ER counterselectivity represents a significant step towards the development of new highly selective therapeutics for cancer and other diseases.
authors.affiliation: Department of Cell Biology & Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, United States.
authors.forename: Megan K
authors.initials: MK
authors.lastname: Dennis
authors.forename: Angela S
authors.initials: AS
authors.lastname: Field
authors.forename: Ritwik
authors.initials: R
authors.lastname: Burai
authors.forename: Chinnasamy
authors.initials: C
authors.lastname: Ramesh
authors.forename: Whitney K
authors.initials: WK
authors.lastname: Petrie
authors.forename: Cristian G
authors.initials: CG
authors.lastname: Bologa
authors.forename: Tudor I
authors.initials: TI
authors.lastname: Oprea
authors.forename: Yuri
authors.initials: Y
authors.lastname: Yamaguchi
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Hayashi
authors.forename: Larry A
authors.initials: LA
authors.lastname: Sklar
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Hathaway
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Arterburn
authors.forename: Eric R
authors.initials: ER
authors.lastname: Prossnitz
mesh_terms: D000818:Animals; D052117:Benzodioxoles / Q000138:chemical synthesis* / Q000494:pharmacology; D001665:Binding Sites; D015153:Blotting, Western; D019556:COS Cells; D002522:Chlorocebus aethiops; D009682:Magnetic Resonance Spectroscopy; D011804:Quinolines / Q000138:chemical synthesis* / Q000494:pharmacology; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors* / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D021241:Spectrometry, Mass, Electrospray Ionization; D017550:Spectroscopy, Fourier Transform Infrared
chemical_list: D052117:Benzodioxoles; C000603178:G36 compound; D011804:Quinolines; D011960:Receptors, Estrogen; D043562:Receptors, G-Protein-Coupled